[conistonwater]

The FDA charges pharma companies for drug reviews (https://www.nature.com/articles/nrd1774), and it works but leads to an appearance of a conflict of interest. They could just make the filing fee equal to what it costs to do a review.

[thrmsforbfast]

Steko's comment might be a good place to continue that particular conversation. Such an approach would require careful design of incentive structures so that patents remain accessible without making the status quo of bullshit patents even worse.